Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

43 results about "Fluroxene" patented technology

Fluroxene (INN, USAN; brand name Fluoromar), or 2,2,2-trifluoroethyl vinyl ether, is a volatile, inhalational anesthetic, and was the first halogenated hydrocarbon anesthetic to be introduced. It was synthesized in 1951, and was introduced for clinical use in 1954, but was voluntarily withdrawn from the market in 1974 due to its potential flammability and accumulating evidence that it could cause organ toxicity. In any case, prior to being discontinued, it had largely been superseded by halothane. Fluroxene is metabolized to 2,2,2-trifluoroethanol, a compound responsible for some of the toxicity seen with fluroxene use.

2,3,5-Trifluoro-4-difluoro(3,4,5-trifluorophenylol)methyl-benzaldehyde, its synthetic method and its application in preparation of liquid crystal compound

The invention provides 2,3,5-trifluoro-4-difluoro(3,4,5-trifluorophenylol)methyl-benzaldehyde (a compound of formula 8), and its preparation method. The compound can be used to synthesize a compound with the structure represented by formula I as an intermediate compound. The compound of formula 8 is prepared from 2,3,4,5-tetrafluorobenzoic aid. The method has the advantages of simple operation, high yield, low cost, and suitableness for industrial production.
Owner:JIANGSU HECHENG ADVANCED MATERIALS

Preparation method of octadecanedioic acid mono-tert-butyl ester-PFP

The invention discloses a preparation method of octadecanedioic acid mono-tert-butyl ester-PFP. The preparation method comprises the steps of preparation of a compound 1 and preparation of octadecanedioic acid mono-tert-butyl ester-PFP; wherein the preparation method of the octadecanedioic acid mono-tert-butyl ester-PFP comprises the following steps: A1, adding a compound 1, pyridine and DMF into a reaction kettle, starting stirring for completely dissolving the components, dropwise adding trifluoroacetic acid pentafluorophenol ester, separating out a solid, and reacting the components; A2, post-treatment: carrying out suction filtration on the reaction liquid, collecting light yellow or white solids, carrying out DMF pulping and suction filtration, collecting products, and carrying out vacuum drying to obtain 1.4 Kg of products. Herein,the prepared compound 1 is simple in reaction and post-treatment and can also be directly used for preparing octadecanedioic acid mono-tert-butyl ester-PFP, and a solid generated in the reaction for preparing the octadecanedioic acid mono-tert-butyl ester-PFP is the product, and a high-purity product can be obtained only by simple pulping. The coupling difficulty of octadecanedioic acid or tert-butyl ester of octadecanedioic acid used for preparing side chains of polypeptides such as semaglutide and the like is relatively high, while the octadecanedioic acid mono-tert-butyl ester-PFP can react only by adding alkali, so that the reaction efficiency is high.
Owner:浙江泽瑞生物医药有限公司

A kind of preparation method of pentafluorophenol

The invention provides a pentafluorophenol preparation method, which comprises: using hexafluorobenzene and potassium hydroxide as raw materials, adding an appropriate amount of tetrabutylammonium hydrogen sulfate, N-sulfopropyl-3-methylpyridine triflate, N-methyl-2-[(2-methylphenoxy)acetyl]hydrazinium methylthioamide and 2,2,6,6-tetramethylpiperidine-oxynitride to a tert-butyl alcohol aqueous solution with a mass fraction of 80-85%, heating to achieve a slight boiling state, carrying out a reflux reaction for 2-3 h, adding an appropriate amount of water, distilling to recover the tert-butyl alcohol solvent, adjusting the PH value of the remaining aqueous solution by using refined hydrochloric acid to 9-10, adsorbing with a functionalized D101 macroporous adsorption resin, acidifying with refined hydrochloric acid to achieve the PH value of 1-2, layering, distilling the upper layer water phase until no oily substance exists, collecting the distilled product, combining the collected product and the lower layer oil phase, rectifying, collecting the distillate at the temperature of 142-144 DEG C, and cooling to a room temperature to obtain the colorless and transparent crystal pentafluorophenol. According to the present invention, the preparation method has advantages of simple and reasonable process, less side reactions, high reaction yield and high product purity, and can meet the quality requirements for the preparation of the high-quality liquid crystal materials and drugs.
Owner:QUZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products